Jagsonpal Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Jagsonpal Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Jagsonpal Pharmaceuticals Ltd.

21 Feb 2025

216.62

-1.86%

Company Update

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

In compliance with Regulation 30 read with Schedule III of the Listing Regulations read with SEBI Master Circular. We wish to inform you that Jagsonpal Pharmaceuticals Limited has signed Business Transfer Agreement (BTA) acquire india business of Resilient Cosme-Ceuticals Private Limited along with the brands associated trademarks.

pdf

Jagsonpal Pharmaceuticals Ltd.

21 Feb 2025

216.62

-1.86%

Company Update

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

With reference to the above we wish to inform you that Company had received the warning letter dated February 05, 2025 from USFDA regarding observations during the inspection of contract manufacturing facility of Jagsonpal.

pdf

Jagsonpal Pharmaceuticals Ltd.

17 Feb 2025

216.62

-1.86%

Company Update

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Pursuant to SEBI (Listing Obligation and Disclosure Requirements) Reg. 2015, as amended, we are pleased to inform you that the Nomination and Remuneration Committee has issued and alloted 22,150 Equity Shares of Rs. 2/ each under JPL ESOP 2022.

pdf

Jagsonpal Pharmaceuticals Ltd.

05 Feb 2025

216.62

-1.86%

Company Update

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And …

BSE India

We wish to inform you that consequent to appointment of Mr. Sachin Jain as Chief Financial Officer of the Company. The Board has approved changes in KMPs authorised to determine materiality event or information for making disclosure.

pdf

Jagsonpal Pharmaceuticals Ltd.

05 Feb 2025

216.62

-1.86%

Company Update

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Please be informed that based on recommendation of Nomination and Remuneration Committee, Audit Committee and Board at their meeting held today has approved appointment of Mr. Sachin Jain as Chief Financial Officer of the Company w.e.f February 05, 2025.

pdf

Jagsonpal Pharmaceuticals Ltd.

29 Jan 2025

216.62

-1.86%

Earnings Call

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Reg. 30 of SEBI (LODR) Reg. 2015, please find enclosed transcript of earning call of Jagsonpal Pharmaceuticals Limited held on January 23, 2025 at 10:00 AM.

pdf

Jagsonpal Pharmaceuticals Ltd.

24 Jan 2025

216.62

-1.86%

Company Update

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith copies of advertisement published on January 24, 2025 in ''Business Standard'' (English) and ''Business Standard'' (Hindi) newspaper providing extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024.

pdf

Jagsonpal Pharmaceuticals Ltd.

23 Jan 2025

216.62

-1.86%

Earnings Call

JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

The audio recording of the Jagsonpal Pharmaceuticals Limited Q3FY25 Earnings Conference Call held on January 23, 2025 at 10:00 AM for discussion of Q3FY25 Financial Results is available on the Company's website.

pdf